<- Go Home
eXoZymes, Inc.
eXoZymes, Inc. operates as a development stage biotechnology company. The company focuses on the development of enzyme modules and cell-free exozyme biosolutions for synthetic biology manufacturing. The company was formerly known as Invizyne Technologies, Inc. and changed its name to eXoZymes, Inc. in February 2025. eXoZymes, Inc. was incorporated in 2014 and is headquartered in Monrovia, California.
Market Cap
$137.6M
Volume
17.8K
Cash and Equivalents
$5.1M
EBITDA
-$8.7M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
N/A
Profit Margin
N/A
52 Week High
$23.99
52 Week Low
$8.50
Dividend
N/A
Price / Book Value
25.59
Price / Earnings
-15.94
Price / Tangible Book Value
25.59
Enterprise Value
$133.8M
Enterprise Value / EBITDA
-16.02
Operating Income
-$9.0M
Return on Equity
940.69%
Return on Assets
-99.79
Cash and Short Term Investments
$5.1M
Debt
$1.3M
Equity
$5.4M
Revenue
N/A
Unlevered FCF
-$4.1M
Sector
Biotechnology
Category
N/A
Hedge Funds that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).
Upgrade to Yellowbrick PremiumYellowbrick Portfolios that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).
Upgrade to Yellowbrick Premium